A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200)
Clinical trial NCT02580058 · COMPLETED
Trial details
- NCT number
- NCT02580058
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-21
- Primary completion
- 2018-09-19
- Enrollment
- 566
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.